Kenvue Inc

Research Kenvue Inc (KVUE) on Bullrun: valuation model: 6.6% undervalued, market cap USD 36.61B, P/E 22.6, dividend yield 4.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerKVUE
ExchangeNYSE
CountryUnited States
SectorConsumer Defensive
IndustryHousehold & Personal Products
CurrencyUSD
Valuation signal6.6% undervalued
Market capUSD 36.61B
P/E22.6
Dividend yield4.4%
Financial periodFY2025
RevenueUSD 15.12B
Revenue growth-2.1%
Net incomeUSD 1.47B
Free cash flowUSD 1.72B
Gross margin58.1%

Valuation Snapshot

Bullrun's latest valuation model marks Kenvue Inc as 6.6% undervalued; latest market cap is USD 36.61B; P/E is 22.6; dividend yield is 4.4%.

About Kenvue Inc

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine;

Frequently asked questions

Is Kenvue Inc overvalued or undervalued?

Bullrun's valuation model currently marks Kenvue Inc as 6.6% undervalued.

What is Kenvue Inc's market cap?

Kenvue Inc's market capitalization is USD 36.61B.

What is Kenvue Inc's P/E ratio?

Kenvue Inc's price-to-earnings (P/E) ratio is 22.6.

Does Kenvue Inc pay a dividend?

Kenvue Inc has a dividend yield of 4.4%.